4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0001193125-25-314741
Director sold 14,000 shares at an average $13.50 ($189,000)
- Director acquired 14,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wagner Heidi L · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +7,000 | $5.97 | $41,790 | 51,930 | D |
| 2025-12-08 | Sale : show line 2 in the form 10b5-1 | −7,000 | $13.00 | $91,000 | 44,930 | D |
| 2025-12-08 | Exercise or conversion : show line 3 in the form 10b5-1 | +7,000 | $5.97 | $41,790 | 51,930 | D |
| 2025-12-08 | Sale : show line 4 in the form 10b5-1 | −7,000 | $14.00 | $98,000 | 44,930 | D |
| Open-market sales · 14,000 sh · avg $13.50 · $189,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-08 | Exercise or conversion : show line 5 in the form 10b5-1 Share Option (right to buy) | −14,000 | 7,000 | D |
Loading xslF345X05/ownership.xml…